IDBS Expands in Asia Pacific

Announces Direct Support, Training and Sales Resources Through new Chinese and Australian Centers – Presents Translational Research and Healthcare Strategy at eResearch Australasia

Guildford, UK, and Burlington, MA — IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that it has expanded its Asia Pacific presence with new centers in both China and Australia. From these new offices IDBS is now providing customers with direct local support and training, as well as sales and business development across the entire portfolio of IDBS products; ActivityBase, E-WorkBook and InforSense Suites.

IDBS now has the largest presence in China of any life sciences software company.

IDBS’ organisation in China is being run from Shanghai by David Hadfield and serves customers in mainland China, Hong Kong and Taiwan. Mr. Hadfield was formerly Senior Vice President and general manager at Spotfire and previously held senior executive roles at Molecular Devices Inc., and Oxford GlycoSciences, as well as senior management positions at Applied Biosystems.

IDBS has also expanded its existing Australian operations under the leadership of Conor Higgins. This organisation will serve customers in Australia, New Zealand and South East Asia. Mr Higgins, who has already developed a strong IDBS user base in Australia, has over 15 years experience in the IT field specializing in data security, compliance and management. He has previously helped organizations such as Watchfire (IBM), Ironport (CSICO), and Acopia (F5Networks) expand their businesses in the region.

“IDBS is well known for developing close, constructive relationships with our customers. We are extremely pleased to be able to make this major commitment to the region and serve our expanding customer base with the highest level of dedicated, culturally aware, support and training. Our proven Translational Research offerings also have a significant role to play in this expansion.” said Neil Kipling, founder and CEO of IDBS.

Chris Molloy, VP Corporate Development and APAC added: “We are delighted to have two such experienced and dedicated leaders in place as we continue our regional development. This investment reflects the rapid growth of the R&D market in Asia Pacific and the ‘must-have’ requirement for robust enterprise data management solutions which we already provide in the region and worldwide.”

Professor Yike Guo, Chief Innovation Officer at IDBS, will give two presentations at the eResearch Australasia conference in Sydney, Australia, November 9-13, 2009. His session on Research Informatics for Translational Medicine will provide an overview of the design principles of developing a translational research platform in drug discovery and healthcare and will highlight the work done by IDBS.

Professor Guo’s presentation on Informatics for Value Based Healthcare will address the fundamental challenges in developing an information-driven healthcare infrastructure to support tracking patient costs across the entire clinical pathway: from diagnosis to treatment to outcome.

For more information visit http://www.eresearch.edu.au/.

About IDBS

IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. The company’s ActivityBase and E-WorkBook Suites provide gold standard chemistry and biology data support from target validation to GxP validated phases of the R&D process. The company supports long term relationships with the leading research organizations, maximizing the value of research data by enabling the capture, storage, sharing and use of data, while protecting intellectual property across the spectrum of research activities.

Headquartered in Guildford, UK, IDBS has worldwide coverage, with U.S. offices in California, New Jersey and Massachusetts, consultancy teams across Europe and a network which delivers IDBS products and advisory services across Asia. Founded in 1989, IDBS employs more than 170 people worldwide.

< | >